AHA Scientific Sessions 2026 Abstract
All Lipid-Lowering Drug Classes Show Similar Attenuation of Cardiovascular Benefit with Increasing Baseline Risk: A Bayesian Hierarchical Meta-Regression of Prevention Trials
Meta-analysis of randomized trialsInterventions